These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
789 related items for PubMed ID: 24606637
1. HPV vaccines to prevent cervical cancer and genital warts: an update. Dochez C, Bogers JJ, Verhelst R, Rees H. Vaccine; 2014 Mar 20; 32(14):1595-601. PubMed ID: 24606637 [Abstract] [Full Text] [Related]
2. Developments in L2-based human papillomavirus (HPV) vaccines. Schellenbacher C, Roden RBS, Kirnbauer R. Virus Res; 2017 Mar 02; 231():166-175. PubMed ID: 27889616 [Abstract] [Full Text] [Related]
3. Prophylactic HPV vaccines: reducing the burden of HPV-related diseases. Villa LL. Vaccine; 2006 Mar 30; 24 Suppl 1():S23-8. PubMed ID: 16194583 [Abstract] [Full Text] [Related]
4. Spotlight on quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine(Gardasil®) in the prevention of premalignant genital lesions, genital cancer, and genital warts in women. McCormack PL, Joura EA. BioDrugs; 2011 Oct 01; 25(5):339-43. PubMed ID: 21942919 [Abstract] [Full Text] [Related]
5. Human Pappilomavirus (HPV) induced cancers and prevention by immunization. Khaliq SA, Shyum Naqvi SB, Fatima A. Pak J Pharm Sci; 2012 Oct 01; 25(4):763-72. PubMed ID: 23009992 [Abstract] [Full Text] [Related]
7. Preventing cervical cancer and genital warts - How much protection is enough for HPV vaccines? Stanley M. J Infect; 2016 Jul 05; 72 Suppl():S23-8. PubMed ID: 27211079 [Abstract] [Full Text] [Related]
8. [The first vaccine against cancer: the human papillomavirus vaccine]. Bősze P. Orv Hetil; 2013 Apr 21; 154(16):603-18. PubMed ID: 23587540 [Abstract] [Full Text] [Related]
9. Effectiveness of HPV vaccines against genital warts in women from Valencia, Spain. Navarro-Illana E, López-Lacort M, Navarro-Illana P, Vilata JJ, Diez-Domingo J. Vaccine; 2017 Jun 05; 35(25):3342-3346. PubMed ID: 28499554 [Abstract] [Full Text] [Related]
16. Updates on human papillomavirus and genital warts and counseling messages from the 2010 Sexually Transmitted Diseases Treatment Guidelines. Dunne EF, Friedman A, Datta SD, Markowitz LE, Workowski KA. Clin Infect Dis; 2011 Dec 05; 53 Suppl 3():S143-52. PubMed ID: 22080267 [Abstract] [Full Text] [Related]
17. Comparative cost-effectiveness of the quadrivalent and bivalent human papillomavirus vaccines: a transmission-dynamic modeling study. Brisson M, Laprise JF, Drolet M, Van de Velde N, Franco EL, Kliewer EV, Ogilvie G, Deeks SL, Boily MC. Vaccine; 2013 Aug 20; 31(37):3863-71. PubMed ID: 23830974 [Abstract] [Full Text] [Related]
18. Vaccines against human papillomavirus infections: protection against cancer, genital warts or both? Joura EA, Pils S. Clin Microbiol Infect; 2016 Dec 01; 22 Suppl 5():S125-S127. PubMed ID: 28034371 [Abstract] [Full Text] [Related]
19. [Human papillomavirus prophylactic vaccines: stakes and perspectives]. Hantz S, Alain S, Denis F. Gynecol Obstet Fertil; 2006 Dec 01; 34(7-8):647-55. PubMed ID: 16807045 [Abstract] [Full Text] [Related]
20. Human papillomavirus vaccine trials and tribulations: Clinical perspectives. Handler MZ, Handler NS, Majewski S, Schwartz RA. J Am Acad Dermatol; 2015 Nov 01; 73(5):743-56; quiz 757-8. PubMed ID: 26475534 [Abstract] [Full Text] [Related] Page: [Next] [New Search]